These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


238 related items for PubMed ID: 9303595

  • 1. [Temporal cerebellar atrophy following phenytoin therapy].
    Guerrero AL, Paniagua JA, Díaz Cascajo P, Cacho J, Arias P, Martín JA.
    Neurologia; 1997; 12(6):259-61. PubMed ID: 9303595
    [Abstract] [Full Text] [Related]

  • 2. Cerebellar atrophy in an epileptic child: is it due to phenytoin?
    Ahuja SR, Karande S, Kulkarni MV.
    J Postgrad Med; 2000; 46(4):278-9. PubMed ID: 11435657
    [Abstract] [Full Text] [Related]

  • 3. [Cerebellar atrophy and phenytoin poisoning. An MR study].
    Luef G, Marosi M, Felber S, Birbamer G, Aichner F, Bauer G.
    Nervenarzt; 1993 Aug; 64(8):548-51. PubMed ID: 8413755
    [Abstract] [Full Text] [Related]

  • 4. [Cerebellar atrophy in epileptic patients: computer tomography study].
    Kessler C, Henningsen H, Reuther R, Christian W.
    Fortschr Neurol Psychiatr; 1985 Dec; 53(12):437-41. PubMed ID: 4077007
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Phenytoin-related cerebellar degeneration without seizures.
    Rapport RL, Shaw CM.
    Ann Neurol; 1977 Nov; 2(5):437-9. PubMed ID: 617582
    [Abstract] [Full Text] [Related]

  • 7. [Dose-dependent relationship of chronic use of phenytoin and cerebellar atrophy in patients with epilepsy].
    Del Negro A, Dantas CD, Zanardi V, Montenegro MA, Cendes F.
    Arq Neuropsiquiatr; 2000 Jun; 58(2A):276-81. PubMed ID: 10849627
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Acute cerebellar atrophy caused by diphenylhydantoin intoxication resulting from drug interaction].
    Zuin DR, Neme R, Porta L, Vera J, Lopez OL.
    Rev Neurol; 2000 Jun; 36(2):195-6. PubMed ID: 12589609
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The cerebellum of epileptics.
    Gessaga EC, Urich H.
    Clin Neuropathol; 1985 Jun; 4(6):238-45. PubMed ID: 4075636
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Paradoxical seizures in phenytoin toxicity.
    Chua HC, Venketasubramanian N, Tan CB, Tjia H.
    Singapore Med J; 1999 Apr; 40(4):276-7. PubMed ID: 10487084
    [Abstract] [Full Text] [Related]

  • 16. Phenytoin: effective but insidious therapy for epilepsy in people with intellectual disability.
    Iivanainen M.
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():24-31. PubMed ID: 10030428
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Phenytoin desensitization in a child with symptomatic localization-related epilepsy.
    Itomi S, Okumura A, Ikuta T, Negoro T, Watanabe K.
    Brain Dev; 2007 Mar; 29(2):121-3. PubMed ID: 16935446
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.